Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Brain Neoplasms 8Breast Neoplasms 5Neoplasms 4Head and Neck Neoplasms 3Central Nervous System Neoplasms 3Uterine Cervical Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Oligodendroglioma 2Melanoma 2Lung Neoplasms 2Glioma 2Glioblastoma 2Ependymoma 2Carcinoma, Non-Small-Cell Lung 2Astrocytoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma 1Leukemia, Myeloid, Acute 1

Interventions

Fluorouracil 14Radiotherapy 11Mitomycin 9Radiation 8Capecitabine 8Surveys and Questionnaires 6Drug Therapy 6Cisplatin 6pembrolizumab 5Paclitaxel 4Magnetic Resonance Spectroscopy 4Irinotecan 3Immune Checkpoint Inhibitors 3Cetuximab 3Carboplatin 3Biopsy 3tislelizumab 2durvalumab 2atezolizumab 2aldesleukin 2Therapeutics 2Specimen Handling 2Papillomavirus Vaccines 2Oxaliplatin 2Observation 2Nivolumab 2Cyclophosphamide 2Blood Specimen Collection 2Adoptive Transfer 2toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anus Neoplasms × alovudine × Clear all
NCT01717391 2019-03-26

[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers

University of Iowa

Phase 2 Completed
36 enrolled 5 charts
GastrointestinalGenitourinaryGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡